Navigation Links
FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Date:9/19/2011

Serious skin infections, as well as infections of the abdomen, urinary tract and ear, were more frequent in patients treated with Prolia. Patients should be advised to seek prompt medical attention if they develop signs or symptoms of severe infection, including cellulitis. Endocarditis was reported more frequently in the Prolia-treated patient group. Epidermal and dermal adverse events such as dermatitis, rashes and eczema have been reported. Discontinuation of Prolia should be considered if severe symptoms develop.

In clinical trials in women with postmenopausal osteoporosis, Prolia resulted in significant suppression of bone remodeling. The significance of these findings is unknown. The long-term consequences of the degree of suppression of bone remodeling observed with Prolia may contribute to adverse outcomes such as osteonecrosis of the jaw (ONJ), atypical fractures and delayed fracture healing. ONJ has been reported in patients with Prolia. Patients should be monitored for these adverse outcomes.

The most common adverse reactions (> 5 percent and more common than placebo) in patients with postmenopausal osteoporosis were back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia and cystitis. Pancreatitis has also been reported. The most common (per patient incidence > 10 percent) adverse reactions reported with Prolia in patients with bone loss receiving androgen deprivation therapy for prostate cancer or adjuvant aromatase inhibitor therapy for breast cancer are arthralgia and back pain.  Pain in extremity and musculoskeletal pain have also been reported in clinical trials.  

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics.  A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient.  Amgen th
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014   Edison Nation Medical ... a worldwide search for product ideas to improve ... Promising ideas uncovered through the 6-month search ( ... device manufacturers and healthcare retailers with whom Edison ... of individuals age 65 and older. ...
(Date:8/28/2014)... , Aug. 28, 2014  In recognition of ... health complications from the flu, pneumonia, shingles and ... have declared September to be Senior Vaccination ... age, it is important that adults ages 65 ... their vaccinations. CVS pharmacists and MinuteClinic nurse practitioners ...
(Date:8/28/2014)... Orthopaedics, the Official Joint Replacement Products of the PGA TOUR ... to golf fans at the next stop of the FedEx ... company,s fan destination – "The Stryker Mobility Zone" – will ... TPC Boston in Norton, MA starting ... the Deutsche Bank Championship, Stryker will be providing golf fans ...
Breaking Medicine Technology:Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5
(Date:8/28/2014)... 2014 (HealthDay News) -- Lack of sleep not only puts ... at increased risk for obesity, researchers warn. The study ... they were aged 16 and 21. Nearly one-fifth of them ... they were age 16, and this group was 20 percent ... who got more than eight hours of sleep per night ...
(Date:8/28/2014)... NJ Top Docs Presents Dr. Christophe ... NJ Top Doc, Dr. Christophe Oliveira, has just ... examiner for the department of transportation. Dr. Oliveira ... perform all drug testing for commercial drivers. , ... musculoskeletal disorders including disk herniations, spinal stenosis, muscle ...
(Date:8/28/2014)... In 2012, The Ben & Catherine Ivy Foundation ... brain cancer research projects at the Translational Genomics ... officially received the final regulatory approval from University ... for the trial can begin. , In the ... Trial," TGen and its clinical partners will lead ...
(Date:8/28/2014)... New York (PRWEB) August 28, 2014 ... mount in courts around the U.S., Bernstein Liebhard LLP ... is touting devices like Mirena as ideal birth control ... Daily Press, the authors of the study point out ... preventing pregnancy than other methods favored by this patient ...
(Date:8/28/2014)... August 28, 2014 BioProcess ... delivering cutting-edge information focused on the development ... an agreement with Pall Life Sciences to ... BioProcess International Awards – the most honorable ... , The awards allow the industry to ...
Breaking Medicine News(10 mins):Health News:Less Sleep in Teen Years Tied to More Pounds at 21 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 3Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 4Health News:Pall Life Sciences Signs on as Program Sponsor of the 2014 BioProcess International Awards 2Health News:Pall Life Sciences Signs on as Program Sponsor of the 2014 BioProcess International Awards 3
... , , , ... regulations take effect under the HITECH Act. HIPAA-covered entities, ... notify affected individuals, the Secretary of Health and Human Services ... information (PHI) is breached. With these new rules in ...
... Researchers have shown for the first time that patterns of ... cancer has started to spread in melanoma patients, and to ... much surgery, if any, is required and to predict the ... cancer congress, ECCO 15 ESMO 34 [1], in Berlin ...
... ... Home Training and Consulting Inc., an industry leader in Continuous Process Improvement ... Sigma Yellow Belt Course available for free. This will help thousands of ... also allow potential Lean Six Sigma Green Belt and Black Belt Candidates ...
... ... Software environment with Strategic,s validation toolkit , ... Cardiff-by-the-Sea, Calif. (PRWEB) September 23, 2009 -- Strategic Information ... solutions, today announced an expanded Alliance relationship with QAD Inc (Nasdaq: QADI), ...
... NEW YORK, Sept. 23 Grammy Award-winning singer-songwriter John Legend ... Nikki Beach Midtown for Project Sunshine,s fall fundraiser to benefit children ... 48" x 32" mixed media portrait of the singer that was ... charity. , , (Photo: ...
... , , IRVINE, Calif., Sept. ... Maggots(TM) in the United States, announced today that its Laboratory ... Limb Salvage conference in Washington, DC, from September 24 to ... the company,s Medical Maggots(TM) product (disinfected Phaenicia sericata ...
Cached Medicine News:Health News:Healthcare Breach Notification Rules Take Effect; ID Experts Offers Complimentary Tool to Measure Organizations' Breach Index 2Health News:Healthcare Breach Notification Rules Take Effect; ID Experts Offers Complimentary Tool to Measure Organizations' Breach Index 3Health News:Ultrasound can predict tumor burden and survival in melanoma patients 2Health News:Ultrasound can predict tumor burden and survival in melanoma patients 3Health News:Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 2Health News:Strategic Information Group Announces QAD Enterprise Validation Partnership 2Health News:Strategic Information Group Announces QAD Enterprise Validation Partnership 3Health News:Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 2Health News:Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 3
Delicate membrane hook/pick with hook on side of instrument for engaging membranes. 20 gauge shaft with balanced titanium handle. Dark finish for reduced glare. Left....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 110 degrees. Most popular size or model....
Excellent for manipulation of the intraocular lens in the capsular bag. The angled and curved shaft allows the instrument to reach across the implant and catch the optic/ haptic junction to facilitat...
Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
Medicine Products: